Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
pharmaceutical manufacturers in Europe:
sales of 39.59 billion Euro [US$43.69 billion]
of which 42%
was Pharmaceuticals & Biological Products),
of the United Kingdom
(£30.82 billion [US$38.96 billion]
of which 56%
was Pharmaceuticals), and
based in Switzerland
(51.94 billion Swiss Francs [US$52.09 billion]
of which 66%
was Innovative Medicines).
During the year ended December of 2018, sales at
Sanofi S.A. were 35.68 billion Euro (US$39.38 billion).
decrease of 1.5%
versus 2017, when the company's sales were 36.20 billion Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Sanofi S.A. had sales
of 33.31 billion Euro.
Contributing to the drop in overall sales was the 17.6% decline
in Pharmaceuticals, from 29.95 billion Euro to 24.69 billion Euro.
However, these declines were partially offset by the increase in sales of
Vaccines (up 0.3% to 5.12 billion Euro)